Cargando…

Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity

The conventional mono-chemotherapy still suffers from unsatisfied potency for cancer therapy due to tumor heterogeneity and the occurrence of drug resistance. Combination chemotherapy based on the nanosized drug delivery systems (nDDSs) has been developed as a promising platform to circumvent the li...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Honglei, Wu, Yanjuan, Xu, Xiao, Chen, Chen, Xue, Xiukun, Xu, Ben, Li, Tianduo, Chen, Zhaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795977/
https://www.ncbi.nlm.nih.gov/pubmed/33375302
http://dx.doi.org/10.3390/polym13010067
_version_ 1783634572125143040
author Zhang, Honglei
Wu, Yanjuan
Xu, Xiao
Chen, Chen
Xue, Xiukun
Xu, Ben
Li, Tianduo
Chen, Zhaowei
author_facet Zhang, Honglei
Wu, Yanjuan
Xu, Xiao
Chen, Chen
Xue, Xiukun
Xu, Ben
Li, Tianduo
Chen, Zhaowei
author_sort Zhang, Honglei
collection PubMed
description The conventional mono-chemotherapy still suffers from unsatisfied potency for cancer therapy due to tumor heterogeneity and the occurrence of drug resistance. Combination chemotherapy based on the nanosized drug delivery systems (nDDSs) has been developed as a promising platform to circumvent the limitations of mono-chemotherapy. In this work, starting from cisplatin and curcumin (Cur), we prepared a dual drug backboned shattering polymeric nDDS for synergistic chemotherapy. By in situ polymerization of the Cur, platinum (IV) complex-based prodrug monomer (DHP), L-lysine diisocyanate (LDI), and then conjugation with a hydrophilic poly (ethylene glycol) monomethyl ether (mPEG) derivative, a backbone-type platinum (IV) and Cur linkage containing mPEG-poly(platinum-co-Cur)-mPEG (PCPt) copolymer was synthesized. Notably, the platinum (IV) (Pt (IV)) and Cur were incorporated into the hydrophobic segment of PCPt with the fixed drugs loading ratio and high drugs loading content. The batch-to-batch variability could be decreased. The resulting prodrug copolymer then self-assembled into nanoparticles (PCPt NPs) with an average diameter around 100 nm, to formulate a synergetic nDDS. Importantly, PCPt NPs could greatly improve the solubility and stability of Cur. In vitro drug release profiles have demonstrated that PCPt NPs were stable in PBS 7.4, rapid burst release was greatly decreased, and the Pt and Cur release could be largely enhanced under reductive conditions due to the complete dissociation of the hydrophobic main chain of PCPt. In vitro cell viability test indicated that PCPt NPs were efficient synergistic chemotherapy units. Moreover, PCPt NPs were synergistic for cisplatin-resistant cell lines A549/DDP cells, and they exhibited excellent reversal ability of tumor resistance to cisplatin. This work provides a promising strategy for the design and synthesis of nDDS for combination chemotherapy.
format Online
Article
Text
id pubmed-7795977
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77959772021-01-10 Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity Zhang, Honglei Wu, Yanjuan Xu, Xiao Chen, Chen Xue, Xiukun Xu, Ben Li, Tianduo Chen, Zhaowei Polymers (Basel) Article The conventional mono-chemotherapy still suffers from unsatisfied potency for cancer therapy due to tumor heterogeneity and the occurrence of drug resistance. Combination chemotherapy based on the nanosized drug delivery systems (nDDSs) has been developed as a promising platform to circumvent the limitations of mono-chemotherapy. In this work, starting from cisplatin and curcumin (Cur), we prepared a dual drug backboned shattering polymeric nDDS for synergistic chemotherapy. By in situ polymerization of the Cur, platinum (IV) complex-based prodrug monomer (DHP), L-lysine diisocyanate (LDI), and then conjugation with a hydrophilic poly (ethylene glycol) monomethyl ether (mPEG) derivative, a backbone-type platinum (IV) and Cur linkage containing mPEG-poly(platinum-co-Cur)-mPEG (PCPt) copolymer was synthesized. Notably, the platinum (IV) (Pt (IV)) and Cur were incorporated into the hydrophobic segment of PCPt with the fixed drugs loading ratio and high drugs loading content. The batch-to-batch variability could be decreased. The resulting prodrug copolymer then self-assembled into nanoparticles (PCPt NPs) with an average diameter around 100 nm, to formulate a synergetic nDDS. Importantly, PCPt NPs could greatly improve the solubility and stability of Cur. In vitro drug release profiles have demonstrated that PCPt NPs were stable in PBS 7.4, rapid burst release was greatly decreased, and the Pt and Cur release could be largely enhanced under reductive conditions due to the complete dissociation of the hydrophobic main chain of PCPt. In vitro cell viability test indicated that PCPt NPs were efficient synergistic chemotherapy units. Moreover, PCPt NPs were synergistic for cisplatin-resistant cell lines A549/DDP cells, and they exhibited excellent reversal ability of tumor resistance to cisplatin. This work provides a promising strategy for the design and synthesis of nDDS for combination chemotherapy. MDPI 2020-12-26 /pmc/articles/PMC7795977/ /pubmed/33375302 http://dx.doi.org/10.3390/polym13010067 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Honglei
Wu, Yanjuan
Xu, Xiao
Chen, Chen
Xue, Xiukun
Xu, Ben
Li, Tianduo
Chen, Zhaowei
Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
title Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
title_full Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
title_fullStr Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
title_full_unstemmed Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
title_short Synthesis Characterization of Platinum (IV) Complex Curcumin Backboned Polyprodrugs: In Vitro Drug Release Anticancer Activity
title_sort synthesis characterization of platinum (iv) complex curcumin backboned polyprodrugs: in vitro drug release anticancer activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795977/
https://www.ncbi.nlm.nih.gov/pubmed/33375302
http://dx.doi.org/10.3390/polym13010067
work_keys_str_mv AT zhanghonglei synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT wuyanjuan synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT xuxiao synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT chenchen synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT xuexiukun synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT xuben synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT litianduo synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity
AT chenzhaowei synthesischaracterizationofplatinumivcomplexcurcuminbackbonedpolyprodrugsinvitrodrugreleaseanticanceractivity